LUPRON DEPOT (leuprolide acetate for extended-release injectable suspension) is a hormonal medication first approved by Health Canada in 1989 for advanced prostate cancer, and later for various ...

(RTTNews) - AbbVie (ABBV) announced that a new 6-month 45mg LUPRON DEPOT, or leuprolide acetate for extended-release injectable suspension, strength has received Health Canada approval for the ...

The diagnosis changed his world, even though he knew it would one day come. More than one doctor had told Greenwood resident Greg Hill that “every man is going to get prostate cancer if he lives long ...

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment. Initial diagnosis and treatment left the author feeling weak and ...

LEXINGTON, Ky. (WKYT) - September is Prostate Cancer Awareness Month. The disease is so prevalent in the U.S. a new case is diagnosed every two minutes, and death related to that particular cancer ...